124 related articles for article (PubMed ID: 33823471)
1. Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression: An exploratory study in the PPMI database.
Udovin L; Otero-Losada M; Bordet S; Chevalier G; Quarracino C; Capani F; Pérez-Lloret S
Parkinsonism Relat Disord; 2021 May; 86():34-37. PubMed ID: 33823471
[TBL] [Abstract][Full Text] [Related]
2. Renin-angiotensin system blockers affect cognitive decline in Parkinson's disease: The PPMI dataset.
Yang J; Gao Y; Duan Q; Qiu Y; Feng S; Zhan C; Huang Y; Zhang Y; Ma G; Nie K; Wang L
Parkinsonism Relat Disord; 2022 Dec; 105():90-95. PubMed ID: 36395543
[TBL] [Abstract][Full Text] [Related]
3. Estimation of Renin-Angiotensin-Aldosterone-System (RAAS)-Inhibitor effect on COVID-19 outcome: A Meta-analysis.
Pirola CJ; Sookoian S
J Infect; 2020 Aug; 81(2):276-281. PubMed ID: 32474043
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD.
Lai CC; Wang YH; Wang CY; Wang HC; Yu CJ; Chen L
Int J Chron Obstruct Pulmon Dis; 2018; 13():867-874. PubMed ID: 29563786
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers have no beneficial effect on ablation outcome in chronic persistent atrial fibrillation.
Zheng B; Kang J; Tian Y; Tang R; Long D; Yu R; He H; Zhang M; Shi L; Tao H; Liu X; Dong J; Ma C
Acta Cardiol; 2009 Jun; 64(3):335-40. PubMed ID: 19593943
[TBL] [Abstract][Full Text] [Related]
6. Perioperative angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers for preventing mortality and morbidity in adults.
Zou Z; Yuan HB; Yang B; Xu F; Chen XY; Liu GJ; Shi XY
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD009210. PubMed ID: 26816003
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with abdominal aortic aneurysms: nation-wide cohort study.
Kristensen KE; Torp-Pedersen C; Gislason GH; Egfjord M; Rasmussen HB; Hansen PR
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):733-40. PubMed ID: 25633315
[TBL] [Abstract][Full Text] [Related]
8. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular events in patients with heart failure: a meta-analysis of randomized controlled trials.
Tai C; Gan T; Zou L; Sun Y; Zhang Y; Chen W; Li J; Zhang J; Xu Y; Lu H; Xu D
BMC Cardiovasc Disord; 2017 Oct; 17(1):257. PubMed ID: 28982370
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers reduced dementia risk in patients with diabetes mellitus and hypertension.
Kuan YC; Huang KW; Yen DJ; Hu CJ; Lin CL; Kao CH
Int J Cardiol; 2016 Oct; 220():462-6. PubMed ID: 27390970
[TBL] [Abstract][Full Text] [Related]
10. Use of ACE-inhibitors and falls in patients with Parkinson's disease.
Laudisio A; Lo Monaco MR; Silveri MC; Bentivoglio AR; Vetrano DL; Pisciotta MS; Brandi V; Bernabei R; Zuccalà G
Gait Posture; 2017 May; 54():39-44. PubMed ID: 28258036
[TBL] [Abstract][Full Text] [Related]
11. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis.
Cheng J; Zhang W; Zhang X; Han F; Li X; He X; Li Q; Chen J
JAMA Intern Med; 2014 May; 174(5):773-85. PubMed ID: 24687000
[TBL] [Abstract][Full Text] [Related]
12. Association Between Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Suicide.
Mamdani M; Gomes T; Greaves S; Manji S; Juurlink DN; Tadrous M; Kennedy SH; Antoniou T
JAMA Netw Open; 2019 Oct; 2(10):e1913304. PubMed ID: 31617924
[TBL] [Abstract][Full Text] [Related]
13. Comparison of clinical outcomes between angiotensin-converting-enzyme inhibitors and ARBs in patients with acute myocardial infarction with dyslipidemia after a successful stent implantation.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Anatol J Cardiol; 2020 Jan; 23(2):86-98. PubMed ID: 32011324
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II type 1 receptor blockers as a first choice in patients with acute myocardial infarction.
Lee JH; Bae MH; Yang DH; Park HS; Cho Y; Lee WK; Jeong MH; Kim YJ; Cho MC; Kim CJ; Chae SC;
Korean J Intern Med; 2016 Mar; 31(2):267-76. PubMed ID: 26701233
[TBL] [Abstract][Full Text] [Related]
15. Effects of renin-angiotensin system blockers on renal outcomes and all-cause mortality in patients with diabetic nephropathy: an updated meta-analysis.
Sarafidis PA; Stafylas PC; Kanaki AI; Lasaridis AN
Am J Hypertens; 2008 Aug; 21(8):922-9. PubMed ID: 18535536
[TBL] [Abstract][Full Text] [Related]
16. Protection against death and renal failure by renin-angiotensin system blockers in patients with diabetes and kidney disease.
Shen J; Huang YM; Song XN; Hong XZ; Wang M; Ling W; Zhang XX; Zhao HL
J Renin Angiotensin Aldosterone Syst; 2016 Jul; 17(3):. PubMed ID: 27377659
[TBL] [Abstract][Full Text] [Related]
17. Renin-angiotensin system as a potential target for new therapeutic approaches in Parkinson's disease.
Perez-Lloret S; Otero-Losada M; Toblli JE; Capani F
Expert Opin Investig Drugs; 2017 Oct; 26(10):1163-1173. PubMed ID: 28836869
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients.
Vijan SG
J Indian Med Assoc; 2009 Mar; 107(3):178-82. PubMed ID: 19810392
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive agents acting on the renin-angiotensin system and the risk of sepsis.
Dial S; Nessim SJ; Kezouh A; Benisty J; Suissa S
Br J Clin Pharmacol; 2014 Nov; 78(5):1151-8. PubMed ID: 24803383
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for diabetic nephropathy: a retrospective comparison.
Robles NR; Romero B; Fernandez-Carbonero E; Sánchez-Casado E; Cubero JJ
J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):195-200. PubMed ID: 20026868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]